WHO considers Madagascar COVID drug for clinical trial

The World Health Organisation (WHO) is considering Madagascar’s COVID Organics for clinical observation process.

The President of Madagascar, Andry Rajoelina made this known on Wednesday, saying that he and the Director-General of WHO, Tedros Ghebreyesus, had a successful virtual interaction on COVID Organics.

He said, “Successful exchange with Tedros Ghebreyesus who commends Madagascar’s efforts in the fight against COVID-19 and congratulates us for the discovery of COVID Organics.

“WHO will sign a confidentiality clause on its formulation and will support the clinical observations process in Africa.”

The Malagasy President said the meeting followed the invitation by WHO to register the drug for clinical trials, adding that his country would prove the effectiveness of the COVID Organics.

The country sent consignments of the herbal drug made from Artemisia annua to African nations.

President Muhammadu Buhari received the consignment apportioned to Nigeria from President Umaro Embaló of Guinea Bissau on Saturday, saying it would be subjected to scientific validation.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

x

Check Also

U.S Defence distances self from Trump’s threat to use military against protesters

Pentagon officials distanced themselves from President Donald Trump’s warning that he could use active-duty military forces to clamp down on protests around the country, saying that it would be better to rely on National Guard for law enforcement where needed.